(PRNB) – Corporate News
-
Sanofi (SNY) Company, Principia Biophara Inc., Reports Early Conclusion of Patient Enrollment in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib
-
Sanofi (SNY) announces expiration of HSR waiting period for acquisition of Principia Biopharma (PRNB)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PRNB Stock Lookup